FIELD: medicine.
SUBSTANCE: invention refers to medicine. An agent has a multi-layer structure and contains at least one layer with an included agent, and at least one fibrous layer. It can additionally contain another protective coating. The agent is stored separately from transdermal therapeutic systems. This separately stored agent contacts a transdermal therapeutic system after the latter has been used. The agent can be stored for a long period of time.
EFFECT: described is the agent for the breaking disposal of medicinal active ingredients contained in the transdermal therapeutic systems (TTS).
7 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SELF-DEGRADABLE TRANSDERMAL THERAPEUTIC SYSTEM WITH IMPROVED FUNCTIONAL PARAMETERS AND EFFICACY | 2009 |
|
RU2506948C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING ACTIVE SUBSTANCE BUPRENORPHINE | 2007 |
|
RU2484822C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM WITH HIGH LEVEL OF USING ACTIVE SUBSTANCE AND DOSE ACCURACY | 2007 |
|
RU2454994C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING LAVAND OIL | 2015 |
|
RU2695785C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM AND METHOD FOR PRODUCING THE SYSTEM | 1993 |
|
RU2108812C1 |
| WOUND BANDAGE | 2009 |
|
RU2538808C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM USING HEAT AVAILABLE TO ACCELERATE PENETRATION OF BIOLOGICALLY ACTIVE SUBSTANCES, AND APPLICATION THEREOF | 2004 |
|
RU2348397C2 |
| TRANSDERMAL ADMINISTRATION OF MEMANTINE | 2011 |
|
RU2578971C2 |
| HIGHLY PURE 3,3-DIPHENYLPROPYLAMINO MONOESTERS | 2004 |
|
RU2394019C2 |
| METHOD AND PRESSURE-SENSITIVE SYSTEM FOR DELIVERING DRUGS IN TRANSDERMAL WAY | 1992 |
|
RU2124340C1 |
